Clinical Value of Complement Activation Biomarkers in Overt Diabetic Nephropathy

Clinical Value of Complement Activation Biomarkers in Overt Diabetic Nephropathy

Background: Experimental studies support a role of complement activation in diabetic nephropathy (DN), yet few clinical correlates exist. We evaluated urinary levels of sC5b-9 membrane attack complex (MAC) in patients with overt DN, and examined its association with the glomerular filtration rate (G...

Full description

Bibliographic Details
Main Authors:	Karyne Pelletier, Arnaud Bonnefoy, Hugo Chapdelaine, Vincent Pichette, Matthieu Lejars, François Madore, Soumeya Brachemi, Stéphan Troyanov
Format:	Article
Language:	English
Published:	Elsevier 2019-06-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024919300890

Similar Items

Proteinuria is still useful for the screening and diagnosis of overt diabetic nephropathy
by: Themis Zelmanovitz, et al.
Published: (2022-05-01)

Evaluation of 1,5-Anhydroglucitol as a Biomarker for Type 2 Diabetes Mellitus in Patients without Overt Nephropathy
by: Luiza Cristina Gobor, et al.
Published: (2021-10-01)

Estimating the Change in Renal Function During the First Year of Therapy in ANCA-Associated Vasculitis
by: Fanny Lepeytre, et al.
Published: (2019-04-01)

NEPHROPATHIES ASSOCIATED WITH COMPLEMENT SYSTEM PATHOLOGY
by: V. V. Dlin, et al.
Published: (2017-01-01)

Lower Serum Creatinine Is Associated with Low Bone Mineral Density in Subjects without Overt Nephropathy.
by: Ji Hye Huh, et al.
Published: (2015-01-01)

Modern view on the complement system role in membranous nephropathy
by: Elena S. Kamyshova, et al.
Published: (2022-08-01)

Lectin complement pathway and diabetes mellitus in the pathogenesis of membranous nephropathy
by: Irina Y. Zdravkova, et al.
Published: (2023-08-01)

The classical pathway triggers pathogenic complement activation in membranous nephropathy
by: Larissa Seifert, et al.
Published: (2023-01-01)

Complement activation products in the circulation and urine of primary membranous nephropathy
by: Mu-fan Zhang, et al.
Published: (2019-08-01)

Congenital Deafness Leads to Altered Overt Oculomotor Behaviors
by: Andréanne Sharp, et al.
Published: (2020-04-01)

Expressing emotions overtly? focus on Malaysians
by: Wong, N.L., et al.
Published: (2010)

The interpretation of overt subject pronominals in Turkish
by: Oktay ÇINAR
Published: (2023-12-01)

Iran's overt and covert goals of the European
by: ali asghar mostafavi
Published: (1999-11-01)

A bibliometric analysis of complement in IgA nephropathy from 1991 to 2022
by: Yun Guo, et al.
Published: (2023-07-01)

Inner versus Overt Speech Production: Does This Make a Difference in the Developing Brain?
by: Franziska Stephan, et al.
Published: (2020-12-01)

The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common Diseases?
by: Felix Poppelaars, et al.
Published: (2021-10-01)

Overt spatial attention modulates multisensory selection
by: Jensen, A, et al.
Published: (2018)

A Simple Theory of Overt and Covert Dogwhistles
by: LUCA ALBERTO RAPPUOLI
Published: (2023-12-01)

Multiple Polypoid Angiodysplasia with Obscure Overt Bleeding
by: Jooyoung Lee, et al.
Published: (2016-01-01)

Electromyographic Findings in Overt Hypothyroidism and Subclinical Hypothyroidism
by: Emel Oğuz Akarsu, et al.
Published: (2013-12-01)

Overt speech decoding from cortical activity: a comparison of different linear methods
by: Gaël Le Godais, et al.
Published: (2023-06-01)

Associations between Biomarkers of Complement Activation, Galactose-Deficient IgA1 Antibody and the Updated Oxford Pathology Classification of IgA Nephropathy
by: Yun-Ting Juan, et al.
Published: (2022-07-01)

Urinary complement profile in IgA nephropathy and its correlation with the clinical and pathological characteristics
by: Dongqing Wang, et al.
Published: (2023-03-01)

Actinidia deliciosa as a complemental therapy against nephropathy and oxidative stress in diabetic rats
by: Ali Y. Naoom, et al.
Published: (2023-11-01)

Overactivation of the complement system may be involved in intrarenal arteriolar lesions in IgA nephropathy
by: Wei-yi Guo, et al.
Published: (2022-08-01)

Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events in patients with diabetes and overt nephropathy: a meta-analysis of randomised controlled trials
by: Fan Shunan, et al.
Published: (2018-10-01)

Biomarkers of sickle cell nephropathy in Senegal.
by: El Hadji Malick Ndour, et al.
Published: (2022-01-01)

Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?
by: Mu X, et al.
Published: (2022-01-01)

Biomarkers of sickle cell nephropathy in Senegal
by: El Hadji Malick Ndour, et al.
Published: (2022-01-01)

OUTCOMES OF OVERT AND NON-OVERT DISSEMINATED INTRAVASCULAR COAGULATION USING THE ISTH DIC SCORING SYSTEM IN CHILDREN: A SINGLE-CENTER STUDY
by: Jassada Buaboonnam, et al.
Published: (2023-01-01)

Enhancing the quality of EAP writing through overt teaching.
by: Wee, Roselind, et al.
Published: (2009)

Orthographic learning in adults through overt and covert reading
by: Anna Chrabaszcz, et al.
Published: (2023-11-01)

No Advantage for Separating Overt and Covert Attention in Visual Search
by: W. Joseph MacInnes, et al.
Published: (2020-05-01)

Primary Prophylaxis of Overt Hepatic Encephalopathy: Is It Time to Consider It?
by: Jessica Faccioli, et al.
Published: (2023-06-01)

Double-lumen duodenum with obscure overt GI bleeding
by: Robert Bechara, MD, et al.
Published: (2018-06-01)

Overt and Occult Hypoxemia in Patients Hospitalized With COVID-19
by: Shrirang M. Gadrey, MBBS, MPH, et al.
Published: (2023-01-01)

Free complement and complement containing extracellular vesicles as potential biomarkers for neuroinflammatory and neurodegenerative disorders
by: Marlies Burgelman, et al.
Published: (2023-01-01)

Neurofilament light chain but not glial fibrillary acidic protein is a potential biomarker of overt hepatic encephalopathy in patients with cirrhosis
by: Koos de Wit, et al.
Published: (2024-05-01)

Comparative Study of Complement Biomarkers in Schizophrenic Patients
by: Ram Kumar Solanki, Ranjana Solanki, Pankaj JP, Rishika Agarwal, Anu Shekhawat, Kuldeep Singh Yadav
Published: (2024-03-01)

Complement as a Biomarker for Systemic Lupus Erythematosus
by: Masahiro Ayano, et al.
Published: (2023-02-01)